|
Parkin D M, Bray F, Ferlay J. Global cancer statistics, 2002 [J]. CA-A Cancer Journal for Clinicians, 2005(2):74.
|
|
Blum M A, Takashi T, Suzuki A. Management of localized gastric cancer [J]. Journal of Surgical Oncology, 2013(3):265.
|
|
Andry G, Hamoir M, Locati LD. Management of salivary gland tumors [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2012(9):1161.
|
|
Cervantes A, Roda D, Tarazona N. Current questions for the treatment of advanced gastric cancer [J]. Cancer Treatment Reviews, 2013(1):60.
|
|
Lenz H J. Pharmacogenomics and colorectal cancer [J]. Advances in Experimental Medicine and Biology, 2006.211.
|
|
Herskovic A, Russell W, Liptay M. Esophageal carcinoma advances in treatment results for locally advanced disease:review [J]. ANNALS OF ONCOLOGY, 2012(5):1095.
|
|
Lordick F, Kang Y K, Chung H C. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advancedgastric cancer (EXPAND):a randomised, open-label phase 3 trial [J]. LANCET ONCOLOGY, 2013(6):490.
|
|
Norguet E, Dahan L, Seitz J F. Targetting esophageal and gastric cancers with monoclonal antibodies [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, (15):1678.
|
|
Janjigian Y Y, Viola-Villegas N, Holland J P. Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET [J]. Journal of Nuclear Medicine, 2013(6):936.
|
|
Field-Ridley A, Heljasvaara R, Pihlajaniemi T. Endostatin, an inhibitor of angiogenesis, decreases after bidirectional superior cavopulmonaryanastamosis [J]. Pediatric Cardiology, 2013(2):291.
|
|
Masiak W, Szponar A, Chodorowska G. Evaluation of endostatin and EGF serum levels in patients with gastric cancer [J]. Polski Przeglad Chirurgiczny, 2011(1):42.
|
|
FengP, ZhangZL, ZhangZH. Effectofendostarcombined with cisplatin on expression of VEGF and Sema3A of Lewis lung cancerrats [J]. Asian Pac J Trop Med, 2013(1):57.
|
|
Jin F, Ji H, Jia C. Synergistic antitumor effects of endostar in combination with oxaliplatin via inhibition of HIF and CXCR4 in the colorectal cell line SW1116 [J]. PloS one, 2012, (10):e47161.
|
|
Rong B, Yang S, Li W. Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer [J]. WORLD Journal OF SURGERY Oncol, 2012.170.
|
下载:
苏公网安备 32100302010246号
